Related Experiment Video

Updated: Jan 3, 2026

Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
03:02

Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification

Published on: July 25, 2025

460

Dexmedetomidine prevents desflurane-induced motor neuron death through NF-KappaB pathway

Wenxun Liu1, Xiaohong Zhou1, Yun Wang1

  • 1Department of Anesthesiology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, China.

Cell Biochemistry and Function
|November 28, 2019
PubMed

Insights

Desflurane harms motor neuron viability and function. Dexmedetomidine protects motor neurons from desflurane toxicity by modulating NF-KappaB signaling, offering potential clinical applications.

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Pharmacology

Background:

  • Desflurane is a widely used general anesthetic.
  • Recent studies suggest desflurane may cause neurotoxicity.
  • Concerns exist regarding desflurane's impact on neuronal health.

Purpose of the Study:

  • To investigate the neurotoxic effects of desflurane on motor neurons.
  • To determine if dexmedetomidine can protect motor neurons from desflurane-induced damage.
  • To elucidate the signaling pathways involved in this neuroprotection.

Main Methods:

  • In vitro studies on motor neuron viability and maturation.
  • Assessment of NF-KappaB signaling pathway activation.
  • Evaluation of motor function and memory recovery in animal models.

Main Results:

  • Desflurane exposure impaired motor neuron viability and maturation.
  • Dexmedetomidine treatment attenuated desflurane's neurotoxic effects.
  • Dexmedetomidine-mediated protection involved the NF-KappaB signaling pathway.
  • Dexmedetomidine administration recovered motor function and memory deficits caused by desflurane.

Conclusions:

  • Desflurane exhibits neurotoxic effects on motor neurons.
  • Dexmedetomidine demonstrates significant neuroprotective properties against desflurane-induced neurotoxicity.
  • Dexmedetomidine's mechanism involves modulation of the NF-KappaB pathway.
  • Dexmedetomidine shows promise for clinical application in preventing anesthetic-related neurotoxicity.
Keywords:
NF-KappaB pathwaydesfluranedexmedetomidinemotor neuron

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.0K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.4K

Related Concept Videos

Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
2.6K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
826
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
535
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action01:17

Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action

Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.7K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
831
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
525